Head-To-Head Review: Innospec (IOSP) & Its Peers

Innospec (NASDAQ: IOSP) is one of 52 publicly-traded companies in the “Specialty Chemicals” industry, but how does it compare to its rivals? We will compare Innospec to similar businesses based on the strength of its earnings, dividends, institutional ownership, valuation, profitability, risk and analyst recommendations.


This table compares Innospec and its rivals’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Innospec 7.22% 14.77% 8.39%
Innospec Competitors -2.56% 9.10% 3.87%

Risk & Volatility

Innospec has a beta of 1.18, meaning that its stock price is 18% more volatile than the S&P 500. Comparatively, Innospec’s rivals have a beta of 1.59, meaning that their average stock price is 59% more volatile than the S&P 500.

Analyst Recommendations

This is a summary of recent ratings and recommmendations for Innospec and its rivals, as reported by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Innospec 0 0 1 0 3.00
Innospec Competitors 164 1022 1275 24 2.47

Innospec currently has a consensus target price of $65.00, suggesting a potential upside of 4.84%. As a group, “Specialty Chemicals” companies have a potential downside of 3.11%. Given Innospec’s stronger consensus rating and higher possible upside, research analysts clearly believe Innospec is more favorable than its rivals.

Institutional and Insider Ownership

89.1% of Innospec shares are owned by institutional investors. Comparatively, 69.7% of shares of all “Specialty Chemicals” companies are owned by institutional investors. 2.0% of Innospec shares are owned by insiders. Comparatively, 7.1% of shares of all “Specialty Chemicals” companies are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.


Innospec pays an annual dividend of $0.76 per share and has a dividend yield of 1.2%. Innospec pays out 24.3% of its earnings in the form of a dividend. As a group, “Specialty Chemicals” companies pay a dividend yield of 1.4% and pay out 26.9% of their earnings in the form of a dividend.

Earnings and Valuation

This table compares Innospec and its rivals gross revenue, earnings per share and valuation.

Gross Revenue EBITDA Price/Earnings Ratio
Innospec $1.06 billion $150.30 million 19.81
Innospec Competitors $1.96 billion $302.17 million 12.48

Innospec’s rivals have higher revenue and earnings than Innospec. Innospec is trading at a higher price-to-earnings ratio than its rivals, indicating that it is currently more expensive than other companies in its industry.


Innospec beats its rivals on 9 of the 15 factors compared.

About Innospec

Innospec Inc. is a specialty chemicals company engaged in developing, manufacturing, blending, marketing and supplying of specialty chemicals for use as fuel additives and ingredients for personal care, home care, agrochemical, mining and other applications and oilfield chemicals. The Company operates through four business segments: Fuel Specialties, Performance Chemicals, Oilfield Services and Octane Additives. Its Fuel Specialties develops, manufactures, blends, markets and supplies various specialty chemical products that are used as additives for a range of fuels. Its Performance Chemicals provides technology-based solutions. Its Oilfield Services business supplies drilling, completion and production chemicals. Its Octane Additives business manufactures a fuel additive for use in automotive gasoline and provides services in respect of environmental remediation. Its customers include oil and gas exploration and production companies, fuel users, and oil refiners among others.

What are top analysts saying about Innospec Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Innospec Inc. and related companies.


Leave a Reply

share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit